Date | Compound | Laboratory | Indication | Type of Information |
---|---|---|---|---|
2012-04-06 | adeno-associated viral vector serotype 9 containing the human sulfamidase gene | Laboratorios del Dr. Esteve (Spain) | mucopolysaccharidosis type IIIA (Sanfilippo A syndrome) |
Granting of a patent |
2012-04-06 | allogeneic T cells encoding an exogenous thymidine kinase gene | LTKFarma (France) | acute lymphoblastic leukaemia | |
2012-04-06 | genetically modified human adenovirus encoding human PH20 hyaluronidase | VCN Biosciences (Spain) | pancreatic cancer | |
2011-06-21 | human dermal fibroblasts cultured on a bioresorbable polyglactin mesh | TMC Pharma Services (UK) | epidermolysis bullosa |
Granting of the orphan status in the EU |
2011-06-24 | human embryonic stem-cell-derived retinal pigment epithelial cells | TMC Pharma Services (UK) | Stargardt’s disease |
Granting of a patent |
2012-04-04 | S-farnesylthiosalicylic acid | TMC Pharma Services (UK) | pancreatic cancer | |
2012-04-04 | Sulfonated monophosphorylated mannose oligosaccharide | S-Cubed Limited (UK) | hepatocellular carcinoma | |
2012-04-04 | N-(cyanomethyl)-4-(2-{[4-(morpholin-4-yl)phenyl]amino}pyrimidin-4-yl)benzamide, dihydrochloride salt | CRES Pharmaceuticals (UK) | primary myelofibrosis
|
|
2012-04-04 | mixture of seven synthetic fragments consisting of p21 RAS peptides | Targovax (Norway) | pancreatic cancer | Granting of the orphan status in the EU |
2012-04-06 | low molecular weight dextran sulfate | TikoMed (Sweden) | mobilisation of progenitor cells prior to stem cell transplantation | |
2012-04-04 | acadesine | Advancell (Spain) | multiple myeloma | |
2012-04-04 | peretinoin | Kowa Pharmaceutical Europe (UK) | hepatocellular carcinoma | |
2012-04-04 | pegylated recombinant Erwinia chrysanthemi L-asparaginase | Alize Pharma (France) | acute lymphoblastic leukaemia |
Granting of the orphan status in the EU |
2012-04-04 | fresolimumab | Genzyme (USA - MA), a Sanofi company (France) | focal segmental glomerulosclerosis |
Granting of the orphan status in the EU |
2015-03-25 | sirolimus | Santen Oy (Finland) (subsidiary of Santen Pharmaceutical - Japan) | chronic non-infectious uveitis |
Submission of a Market Application in the EU |
2012-04-04 | N-{[(5S)-3-(3-fluoro-4-thiomorpholin-4-ylphenyl)-2-oxo-1,3-oxazolidin-5-yl]methyl}acetamide | Pfizer (USA - NY) | tuberculosis |
Granting of a patent |
2012-04-04 | hydroxy-propyl-beta-cyclodextrin | Susan French (UK) | Niemann-Pick disease, type C | |
2012-04-04 | everolimus | Novartis (Switzerland) | gastric cancer | |
2012-04-04 | reparixin | Dompé (Italy) | prevention of graft rejection in pancreatic islet transplantation | |
2012-04-04 | recombinant human galactocerebrosidase | ACE Biosciences, Zymenex group (Denmark) | globoid cell leukodystrophy (Krabbe Disease) |
© 2024 Biopharmanalyses - Powered by Samacom+